Search the Newsreel

Dodge & Cox (CVS: CVS) reports 50M-share, 3.9% ownership stake in CVS Health

Dodge & Cox has reported a 3.9% ownership stake in CVS Health Corporation, holding 50,012,765 shares as of June 30, 2026. This represents less than 5% of the outstanding common stock. The firm possesses sole voting power over 47,541,860 shares and sole dispositive power …

CVS Health (CVS) Stock Trades Below Fair Value After A 48% Gain

CVS Health stock has gained 48.3% over the past year but still appears undervalued according to Simply Wall St's analysis. The company trades at a P/E ratio close to the industry average, but significantly below its tailored fair P/E, suggesting the market may be …

CVS Health (CVS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Executive Vice President of Capital Markets - Larry McGrath Chair and Chief Executive Officer - David Joyner Chief Financial Officer - Brian Newman Full Conference Call Transcript Operator: …

Wedge Capital Management L L P NC Has $31.23 Million Position in CVS Health Corporation $CVS

Wedge Capital Management L L P NC reduced its stake in CVS Health Corporation by 16.2% in the second quarter, selling 58,261 shares but still holding 301,882 shares valued at $31.23 million. Other institutional investors showed mixed activity in CVS stock. CVS Health reported …

CVS Health Corp. stock underperforms Tuesday when compared to competitors

CVS Health Corp. stock underperformed on Tuesday, falling 2.27% to $93.50, marking its sixth consecutive day of losses. This decline occurred despite a generally rough trading session for the broader market, with both the S&P 500 Index and Dow Jones Industrial Average also experiencing …

CVS Group (CVSG) Completes Buyback of 194,132 Shares at Up to 1,303.5p in Latest Weekly Update

CVS pharmacy workers in Rhode Island stage walkout over staffing levels

CVS pharmacy workers in Rhode Island have staged a walkout due to staffing levels and burnout, accusing CVS Health Corp. of bad-faith bargaining. This action occurs as CVS plans to utilize pharmacists for its new direct-to-consumer GLP-1 program, adding to their workload. The company …

CVS Health (CVS) Stock Gets Fair Value Bump As Analysts Turn More Constructive

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. The fair value estimate for CVS Health has shifted from US$111.92 to US$114.88, signaling a modest reset in where analysts think the stock could be worth over …

CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks

CVS Health Corporation CVS used its Q2 2026 earnings call to pair stronger 2026 expectations with an early warning about pharmacy-services pressure next year. Management emphasized Aetna's recovery and retail execution. Adjusted EPS of $2.58 topped the Zacks Consensus Estimate of $1.87, while revenues …

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly (LLY) stock extended gains on Wednesday after the pharmaceutical behemoth announced a new direct-to-consumer (DTC) collaboration with CVS Health (CVS). The press release said this team-up aims to improve patient access, affordability, and pharmacy support for Eli Lilly's blockbuster weight-loss treatments, Zepbound …

CVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised ...

This article first appeared on GuruFocus. Revenue: Over $106 billion in Q2 2026, an increase of over 7% year-over-year. Adjusted Operating Income: Approximately $5.2 billion, up 35% from the prior year quarter. Adjusted EPS: $2.58, a significant increase of over 40% year-over-year. Cash Flow …

CVS Stock Drops 5.8% as 2027 Outlook Disappoints

This article first appeared on GuruFocus. CVS Health (NYSE:CVS), a healthcare giant spanning insurance, pharmacy-benefit management and retail pharmacies, delivered another strong quarter on Wednesday, but Wall Street still hit the sell button as the stock fell 5.8% in regular trading. Adjusted earnings jumped …

CVS Health Corp Stock (CVS) Moved Down by 4.65% on Aug 5: Drivers Behind the Movement

CVS Health (CVS) stock declined by 4.65% on August 5th, primarily due to increased medical benefit ratios in its insurance division and a lowered full-year earnings guidance. The company faces ongoing challenges from elevated medical utilization rates, soft consumer spending, and reimbursement headwinds in …

CVS Health Corporation Q2 2026 Earnings Call Summary

CVS Health Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Delivered …

CVS Health Corp. stock underperforms Wednesday when compared to competitors

CVS Health Corp. (CVS) stock fell by 5.08% on Wednesday, closing at $99.12. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising but the S&P 500 Index declining. This marks the second consecutive day of losses for CVS …

CVS forecasts at least $11.5B in 2026 operating cash flow as it raises adjusted EPS guidance to $7.90-$8.10

Earnings Call Insights: CVS Health (CVS) Q2 2026 MANAGEMENT VIEW * "This quarter, each of our operating segments grew earnings and delivered performance that exceeded our expectations," said (CEO, President & Chairman J. Joyner), adding, "We generated adjusted operating income of $5.2 billion and …

CVS Health Stock Is Falling Wednesday: What's Going On? - CVS Health (NYSE:CVS)

CVS Health stock experienced a significant drop on Wednesday despite reporting strong second-quarter earnings that surpassed analyst expectations and raising its full-year guidance. The decline is attributed to profit-taking after a substantial rally, and the company also announced an expanded GLP-1 weight management platform …

CVS Health tops second-quarter estimates, raises full-year profit outlook

CVS Health tops second-quarter estimates, raises full-year profit outlook Proactive uses images sourced from Shutterstock CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue …

CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

CVS Health (CVS) reported $106.1 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.3%. EPS of $2.58 for the same period compares to $1.81 a year ago. The reported revenue represents a surprise of +5.91% over the Zacks …

Earnings Call: CVS Health übertrifft Prognosen für Q2 2026, Aktie fällt aber vorbörslich

(RTTNews) - CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.cvshealth.com/events-and-presentations/default.aspx The views and opinions expressed herein are the views and …

CVS Health Corp earnings beat by $0.75, revenue topped estimates

CVS Health Corp (NYSE: CVS) reported strong second-quarter results, with EPS of $2.58, significantly beating the analyst estimate of $1.83. Revenue also surpassed expectations, reaching $106.1 billion against a consensus of $100.03 billion. The company provided a positive full-year 2026 EPS guidance of $7.90-$8.10, …

CVS Health Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.cvshealth.com/events-and-presentations/default.aspx The views and opinions expressed herein are the views and …

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026 Diversified healthcare company CVS Health (NYSE:CVS) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 7.3% year on year to $106.1 billion. Its non-GAAP profit of $2.58 per share was 39.4% above analysts' …

CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58 Generated year-to-date cash flow from operations of $10.6 billion Raising full-year 2026 guidance: GAAP diluted EPS guidance range to $6.84 to …

CVS Health earns two Gold and one Silver Stevie® Awards for Great Employers

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence WOONSOCKET, R.I., Aug. 4, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its AI Learning Academy earned two Golds and one Silver at the 11th Annual Stevie Awards for Great …

CVS Health (CVS) Q2 Earnings: What To Expect

CVS Health (NYSE: CVS) is set to report its Q2 earnings this Wednesday, with market expectations for flat year-on-year revenue. The company had a strong Q1, beating revenue and EPS estimates. Analysts have largely reconfirmed their estimates, suggesting stability, and CVS stock has seen …

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CVS Health (CVS), which belongs to the Zacks Medical Services industry. This drugstore chain and pharmacy benefits manager has seen …

CVS Health Defeats Whistleblower’s Drug Collusion Fraud Suit

CVS Health Corp. has won a False Claims Act lawsuit filed by whistleblower Ellsworth Associates LLP. The suit alleged that CVS and other entities engaged in an anticompetitive scheme to prevent Medicare Part D recipients from accessing less expensive generic drugs. A US District …

CVS to now fill pet medication prescriptions

CVS Health Corp. has expanded its prescription services to include common pet medications at 9,000 of its pharmacies nationwide. Pet owners can now fill prescriptions for antibiotics, allergy treatments, flea and tick control, insulin, and pain relievers, with options for in-store pickup or delivery. …

CVS Health Corp (1CVS) Q1 2025 Earnings Report - Results, Call & Slides

CVS Health Corp (1CVS) reported strong Q1 2025 earnings, beating analyst expectations for both EPS and revenue. The company recorded an actual EPS of €1.95 against a consensus of €1.48, and actual revenue of €82.01 billion, surpassing the expected €81.20 billion. This represents a …

CVS Health (CVS) Draws Earnings Buzz, Is 6% Undervalued Enough?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recent earnings expectations and fresh store openings have put CVS Health (CVS) in focus …

CVS (CVS) Stock Looks Overvalued As 340B Pricing Lawsuit Looms

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. CVS Health stock has returned 74.8% over the past year, yet its broader valuation checks lean expensive, so investors are weighing a strong share …

Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …